Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Interim Results in the RENEW Trial: A Dose Comparison Study of High-Dose PegInterferon Alfa-2B and Ribavirin for Interferon/Ribavirin Non-Responders with Chronic Hepatitis C

Interim Results in the RENEW Trial: A Dose Comparison Study of High-Dose PegInterferon Alfa-2B and Ribavirin for Interferon/Ribavirin Non-Responders with Chronic Hepatitis C. Hepatology. 2002; 36(4):359A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.